Press

Cybin’s EMBARK Program Announces Graduation of Facilitators

Oct 27 • 4 min read

Cybin Inc. (NEO:CYBN | NYSE American:CYBN), a biopharmaceutical company focused on progressing “Psychedelics to Therapeutics®”, today announced the graduation of highly-skilled facilitators from its EMBARK Psychedelic-Assisted Psychotherapy Training Program. EMBARK is a leading-edge model of psychedelic-assisted psychotherapy co-developed by Alex Belser, Ph.D., and Bill Brennan, Ph.D. The EMBARK model is currently being implemented in two clinical-stage trials,…

Wellbeing Announces Dfinitive Agreement to Divest IRP Health

Oct 27 • 3 min read

Wellbeing Digital Sciences Inc. (NEO: MEDI | OTC: KONEF | FRA: SQ2), an evidence-based mental healthcare company focused on the development and implementation of innovative clinical solutions, including psychedelic medicine and digital therapeutics as supported by clinical research, announces that it has entered into a definitive agreement under which Pathway Health Corp. will acquire all or substantially all…

Delic Labs President and CSO Dr. Markus Roggen to Discuss the Importance of R&D for Business Growth at MJBizCon

Oct 27 • 2 min read

Delic Holdings Corp (CSE: DELC | OTCQB: DELCF | FRA: 6X0), a leader in new medicines and treatments for a modern world, today shared details regarding Delic Labs President and CSO Dr. Markus Roggen’s participation at the 11th annual MJBizCon in Las Vegas, Nevada on November 15, 2022. MJBizScience SymposiumNovember 15, 2022With over 1,400 exhibitors, 35,000 attendees and countless networking opportunities, MJBizCon…

MINDCURE Announces Financial Results for the First Quarter of Fiscal 2023

Oct 27 • 1 min read

Mind Cure Health Inc. (CSE: MCURO | TCQB: MCURF | FRA: 6MH) today announced its financial results for the three months ended August 31, 2022. All amounts are stated in Canadian dollars unless otherwise indicated. The special committee of the Company’s board of directors is continuing to explore, review and evaluate a broad range of strategic alternatives…

Silo Wellness Announces Subsidiary’s Branding Licensing Agreement Terminated

Oct 26 • 5 min read

Silo Wellness Inc. (CSE: SILO | OTCQB: SILFF | FSE: 3K7A), announced that its wholly-owned subsidiary SW Holdings, Inc.’s (“SWHI”) License Agreement with Marley Green, LLC (“Licensor”) dated November 20, 2020, has been terminated as of October 24, 2022, by the licensor due to SWHI ‘s failure to pay its guaranteed minimum royalties of USD$600,000…

Pages: 123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354555657585960616263646566676869707172737475767778798081828384858687888990919293949596979899100101102103104105106107108109110111112113114115116117118119120121122123124125126127128129130131132133134135136137138139140141142143144145146147148149150151152153154155156157158159160161162163164165166167168169170171172173174175176177178179180181182183184185186187188189190191192193194195196197198199200201202203204205206207208209210211212213214215216217218219220221222223224225226227228229230231232233234235236237238239240241242243244245246247248249250251252253254255256257258259260261262263264265266267268269270271272273274275276277278279280281282283284285286287288289290291292293294295296297298299300301302303304305306307308309310311312313314315316317318319320321322323324325326327328329330331332333334335336337338339340341342343344345346347348349350351352353354355356357358359360361362363364365366367368369370371372373374375376377378379380381382383384385386387388389390391392393394395396397398399400401402403404405406407408409410411412413414415416417418419420421422423424425426427428429430431432433434435